Post Scheme of Arrangement, IGL Spirits’ reports its first comparative results: H1 Revenue of Rs 4,837 Cr, Up by 14.3%
NOIDA, India, Nov. 18, 2026 /PRNewswire/ — IGL Spirits Limited has announced its unaudited financial results for Q2 FY27 and H1 FY27, marking its first quarterly and half-yearly results following the demerger of the spirits and biofuel undertaking from India Glycols Limited. The results for the quarter and half year ended September 30, 2026, reflect growth in revenue and profit after tax.
Key Financial Highlights: (Rs. in Crore)
|
Particulars |
Q2 FY27 |
Q2 FY26 |
|
Revenue from Operations |
2,295.41 |
2,080.63 |
|
EBITDA |
124.68 |
124.59 |
|
PAT |
61.20 |
57.56 |
|
Quarterly EPS (in Rs.) |
9.13 |
8.59 |
Key Highlights for Q2 FY27:
In Q2 FY27, IGL Spirits Limited reported a 10.3% year-over-year growth in revenue from operations to Rs. 2,295.41 crore, compared to Rs. 2,080.63 crore in Q2 FY26.
EBITDA for Q2 FY27 stood at Rs. 124.68 crore, as against Rs. 124.59 crore in Q2 FY26.
The Profit After Tax (PAT) for Q2 FY27 stood at Rs. 61.20 crore, compared to Rs. 57.56 crore in Q2 FY26.
Performance in H1, FY27
|
Particulars |
H1 FY27 |
H1 FY26 |
|
Revenue from Operations |
4,837.30 |
4,233.26 |
|
EBITDA |
244.78 |
238.46 |
|
PAT |
120.79 |
112.40 |
|
Half-yearly EPS (in Rs.) |
18.02 |
16.77 |
Key Highlights for H1 FY27:
For H1 FY27, the Company reported a 14.3% year-over-year growth in revenue from operations to Rs. 4,837.30 crore, compared to Rs. 4,233.26 crore in H1 FY26.
EBITDA for H1 FY27 increased by 2.6% to Rs. 244.78 crore, compared to Rs. 238.46 crore in H1 FY26.
The Profit After Tax (PAT) for H1 FY27 increased to Rs. 120.79 crore, as compared to Rs. 112.40 crore in H1 FY26.
Commenting on the results, Mr. Manoj Kumar Rai, Executive Director and Chief Operating Officer, IGL Spirits Limited, said, “This demerger represents a pivotal milestone in our strategic evolution, sharpening our focus across both our spirits and biofuel businesses. Leveraging our proven capabilities in each segment, we are committed to expanding our market leadership, driving operational excellence, and capturing high-value growth opportunities to deliver sustainable, long-term value for our stakeholders.”
Note:
1) The Honorable National Company Law Tribunal (“NCLT”) vide its order dated July 17, 2026 has approved the scheme of arrangement for the demerger of India Glycols Limited ( “the Demerged Company”) biopharma undertaking and spirits & biofuel undertaking on going concern basis to Ennature Bio Pharma Limited and IGL Spirits Limited (“the Company”) (“Scheme”) respectively. The order was filed with the Registrar of Companies on September 01, 2026. In terms of the Scheme, all assets and liabilities of the spirits and biofuel undertaking of the Demerged Company were transferred and vested into the Company on the appointed date i.e. April 01, 2026.
2) The company has given accounting effect of the Scheme in the above results in accordance with the accounting treatment prescribed under the Scheme and Appendix C of Ind AS 103- “Business combination of entities under common control”. Accordingly, the comparative financial results and other financial information for the quarters/year included in this statement have also been restated to give effect of the Scheme.
View original content:https://www.prnewswire.com/in/news-releases/post-scheme-of-arrangement-igl-spirits-reports-its-first-comparative-results-h1-revenue-of-rs-4-837-cr-up-by-14-3-302943545.html

